Beckman Coulter (Fullerton, CA, USA) will acquire the diagnostic systems portion of Olympus' Life Sciences (Tokyo, Japan) business for 77.45 billion yen, approximately U.S. $800 million. The acquisition will broaden Beckman Coulter's chemistry offering, enabling it to establish a strong position in larger hospital laboratories and universities where higher throughput systems are preferred. More..
